Allergan Slides After Mylan, Revance Report Deal For Botox Biosimilar
March 01, 2018 at 12:25 PM EST
Shares of Allergan are under pressure this morning after Mylan and Revance Therapeutics announced an agreement for the development and commercialization of a proposed biosimilar to Botox.